360 related articles for article (PubMed ID: 28805940)
1. New and current preventive treatment options in actinic keratosis.
Arenberger P; Arenbergerova M
J Eur Acad Dermatol Venereol; 2017 Sep; 31 Suppl 5():13-17. PubMed ID: 28805940
[TBL] [Abstract][Full Text] [Related]
2. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
Feldman SR; Fleischer AB
Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
[TBL] [Abstract][Full Text] [Related]
3. [The real face of actinic keratosis: field of cancerisation and squamous cell carcinoma].
Basset-Seguin N
Eur J Dermatol; 2012 Dec; 22 Suppl 1():5-9. PubMed ID: 23269757
[TBL] [Abstract][Full Text] [Related]
4. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents.
Berman B; Cohen DE; Amini S
Cutis; 2012 May; 89(5):241-50. PubMed ID: 22768439
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.
Puviani M; Barcella A; Milani M
G Ital Dermatol Venereol; 2013 Dec; 148(6):693-8. PubMed ID: 24442053
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.
Philipp-Dormston WG; Müller K; Novak B; Strömer K; Termeer C; Hammann U; Glutsch JW; Krähn-Senftleben G; Lübbert H; Koller M; Szeimies RM;
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1138-1146. PubMed ID: 29150868
[TBL] [Abstract][Full Text] [Related]
7. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
Berman B; Cohen DE; Amini S
Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
[TBL] [Abstract][Full Text] [Related]
8. The importance of treating the field in actinic keratosis.
Stockfleth E
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():8-11. PubMed ID: 28263021
[TBL] [Abstract][Full Text] [Related]
9. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
[TBL] [Abstract][Full Text] [Related]
10. Treatment considerations in actinic keratosis.
Goldenberg G
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():12-16. PubMed ID: 28263018
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for actinic keratosis in eight European centres: a case-control study.
Traianou A; Ulrich M; Apalla Z; De Vries E; Bakirtzi K; Kalabalikis D; Ferrandiz L; Ruiz-de-Casas A; Moreno-Ramirez D; Sotiriadis D; Ioannides D; Aquilina S; Apap C; Micallef R; Scerri L; Pitkänen S; Saksela O; Altsitsiadis E; Hinrichs B; Magnoni C; Fiorentini C; Majewski S; Ranki A; Proby CM; Stockfleth E; Trakatelli M;
Br J Dermatol; 2012 Aug; 167 Suppl 2():36-42. PubMed ID: 22881586
[TBL] [Abstract][Full Text] [Related]
12. Contemporary management of actinic keratosis.
Navarrete-Dechent C; Marghoob AA; Marchetti MA
J Dermatolog Treat; 2021 Aug; 32(5):572-574. PubMed ID: 31621454
[TBL] [Abstract][Full Text] [Related]
13. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.
Lee AD; Jorizzo JL
Cutis; 2009 Sep; 84(3):169-75. PubMed ID: 19842577
[TBL] [Abstract][Full Text] [Related]
14. Evidence for field cancerisation treatment of actinic keratoses with topical diclofenac in hyaluronic acid.
Ulrich M; Pellacani G; Ferrandiz C; Lear JT
Eur J Dermatol; 2014; 24(2):158-67. PubMed ID: 24721544
[TBL] [Abstract][Full Text] [Related]
15. [Organ transplant recipients need intensive control and treatment of skin cancer].
Togsverd-Bo K; Sørensen SS; Hædersdal M
Ugeskr Laeger; 2013 May; 175(20):1408-11. PubMed ID: 23663395
[TBL] [Abstract][Full Text] [Related]
16. Reduced Staphylococcus Abundance Characterizes the Lesional Microbiome of Actinic Keratosis Patients after Field-Directed Therapies.
Kehrmann J; Koch F; Zumdick S; Höwner A; Best L; Masshöfer L; Scharfenberg S; Zeschnigk M; Becker JC; Schadendorf D; Buer J; Roesch A
Microbiol Spectr; 2023 Jun; 11(3):e0440122. PubMed ID: 37212689
[TBL] [Abstract][Full Text] [Related]
17. Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study.
Drago F; Ciccarese G; Cogorno L; Calvi C; Marsano LA; Parodi A
Eur J Dermatol; 2017 Aug; 27(4):382-385. PubMed ID: 28468736
[TBL] [Abstract][Full Text] [Related]
18. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.
Padilla RS; Sebastian S; Jiang Z; Nindl I; Larson R
Arch Dermatol; 2010 Mar; 146(3):288-93. PubMed ID: 20231500
[TBL] [Abstract][Full Text] [Related]
19. [Actinic keratoses].
Hommel T; Szeimies RM
Hautarzt; 2016 Nov; 67(11):867-875. PubMed ID: 27613022
[TBL] [Abstract][Full Text] [Related]
20. Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeam™ of expert clinicians.
Richard MA; Amici JM; Basset-Seguin N; Claudel JP; Cribier B; Dreno B
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):339-346. PubMed ID: 29235161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
